Gökhan Demirayak

8PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Other biomedical and clinical sciences not elsewhere classifiedClinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 17, 2024
The Cytokine Levels of Cord Blood- and Wharton's Jelly-Derived Mesenchymal Stem Cells from Early to Late Passages.

Ayşe Erol Bozkurt, Figen Abatay Sel, Mediha Suleymanoğlu

|Mar 20, 2023
Evaluation of the relationship between mesenchymal stem cells and immune system in vitro conditions.

Ayşe Erol, Figen Abatay Sel, Mediha Süleymanoğlu

|Feb 22, 2023
The in vitro treatment of mesenchymal stem cells for colorectal cancer cells.

Figen Abatay-Sel, Ayse Erol, Mediha Suleymanoglu

|Feb 16, 2023
Increasing Apoptotic Effect of Cord Blood and Wharton's Jelly-derived Mesenchymal Stem Cells on HT-29.

Figen Abatay-Sel, Ayse Erol, Mediha Suleymanoglu

|Aug 24, 2022
Post-recurrence survival analysis of patients with pulmonary recurrence from gynaecologic cancers: a multi-institutional analysis of 122 patients.

Burak Ersak, Serra Akar, Gökhan Demirayak

|Jul 27, 2019
Comparison of laparoendoscopic single-site (LESS) surgery and conventional multiport laparoscopic (CMPL) surgery for hysterectomy: long-term outcomes of abdominal incisional scar.

Gökhan Demirayak, İsa Aykut Özdemir, Cihan Comba

Pageof 2